These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era. Zhan H; Spivak JL Clin Adv Hematol Oncol; 2009 May; 7(5):334-42. PubMed ID: 19521323 [TBL] [Abstract][Full Text] [Related]
10. Oligoarray comparative genomic hybridization in polycythemia vera and essential thrombocythemia. Borze I; Mustjoki S; Juvonen E; Knuutila S Haematologica; 2008 Jul; 93(7):1098-100. PubMed ID: 18591627 [No Abstract] [Full Text] [Related]
11. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders. Macavei I; Galatâr N Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429 [TBL] [Abstract][Full Text] [Related]
12. [Significance of cytogenetic methods in the diagnosis and differential diagnosis of myeloproliferative diseases (review of the literature and personal data)]. Fleĭshman EV; Volkova MA Probl Gematol Pereliv Krovi; 1970 Aug; 15(8):53-8. PubMed ID: 4935743 [No Abstract] [Full Text] [Related]
14. Influence of the assays of endogenous colony formation and serum erythropoietin on the diagnosis of polycythemia vera and essential thrombocythemia. Mossuz P; Semin Thromb Hemost; 2006 Apr; 32(3):246-50. PubMed ID: 16673278 [TBL] [Abstract][Full Text] [Related]
15. Report on essential thrombocythemia. Cancer Genet Cytogenet; 1981 Oct; 4(2):138-42. PubMed ID: 7199375 [No Abstract] [Full Text] [Related]
16. 5q-syndrome presenting as essential thrombocythemia: myelodysplastic syndrome or chronic myeloproliferative disorders? Koike T; Uesugi Y; Toba K; Narita M; Fuse I; Takahashi M; Shibata A Leukemia; 1995 Mar; 9(3):517-8. PubMed ID: 7885050 [No Abstract] [Full Text] [Related]
17. Diagnosis and management of myeloproliferative disorders. Laszlo J; Huang AT Curr Probl Cancer; 1977 Jul; 2(1):1-42. PubMed ID: 268266 [No Abstract] [Full Text] [Related]
18. Essential thrombocythemia, polycythemia vera, and myelofibrosis: current management and the prospect of targeted therapy. Tefferi A Am J Hematol; 2008 Jun; 83(6):491-7. PubMed ID: 18429051 [TBL] [Abstract][Full Text] [Related]